CED Announces Venture Connect 2020 Presenting Companies
RTP, NC January 17, 2020 – The Council for Entrepreneurial Development (CED) today announced the tech and life science companies that have been selected to present at Venture Connect Summit 2020, to be held March 17-19 in Raleigh, NC.
Click here to view the profiles.
“We had a record year this year with an overwhelming response in applications received. It’s going to be an amazing Summit with a building list of over 125 tech and life science companies on stage,” says Miriam Wison, SVP of CED.
Companies will take the stage to present their big ideas in front of a captive audience and potential investors. Venture Connect is the future of tech and life science and an opportunity to grow brand awareness and gain valuable insight on educational topics. We expect over 1400 attendees, over 200 investors and countless valuable connections to be made.
Presenting companies were chosen by a selection committee made up of community members, including active angel investors, local and regional venture capital firms, community and corporate partners.
You will find a diverse selection of presenting companies at Venture Connect including: AI, Augmented Reality, Big Data, Cyber Security, E-Commerce, Smart Devices, Digital Health, Healthy Consumer, Therapeutics, Advanced Diagnostics, Med Device, Ag Tech and more.
2020 Venture Connect Presenting Companies:
Adzerk
Allstacks
Applied LifeSciences and Systems Poultry, Inc.
Arrevus
Baebies, Inc.
Cell Microsystems, Inc
Cereius, Inc
CrediVia
Diveplane CorporationEasyVote Solutions
Enzerna Biosciences, Inc
Evecxia, Inc.
EydisBio, Inc.
Gavilan Biodesign
Gemelli Biotech
IMMvention Therapeutix, Inc
Keen Decision Systems
LearnPlatform
Lindy Biosciences, Inc.
Metabolon, Inc.
Nufabrx
NuPulseCV
ProAxion Inc
RFPI, Inc.
SENTIO
StrongKey
Tellus Therapeutics, Inc.
The Climate Service
Veralox Therapeutics, Inc.
Viatec, Inc.
Voxelight LLC
Wellnecity
ZynBit
6AM City LLC
Achelios Therapeutics
Advanced Chemotherapy Technologies
Advanced Nanocoatings Incorporated
AgEye Technologies
Altis Biosystems, Inc.
AnelleO, Inc.
Aniluxx Biotechnology
Aptus Bioreactors
Ares Immunotherapy
Arpio
Avior Bio Inc
Basking Biosciences, inc
Betr Health
BioAesthetics
BioLink Life Sciences, Inc
BiomedInnovations LLC
Blue Eye Soft Corp
BlueRecruit, Inc.
Bundle
CAARMO
CARL, Inc.
CERCA
CourtRoom5
Coworks
Cytex Therapeutics, Inc.
DataClarity Corporation
DermiSense Inc
Elevon
EncepHEAL Therapeutics
Equity Shift
EternaTear
FeedStation
Floodlight Software
Flow ROI
Green Stream Technologies Inc
Hank AI, Inc
Home Lending Pal
Intake
LabVoice
mesur.io, Inc
Metallum3D Inc
MicroElastic Ultrasound Systems
MuukLabs
MycoMed Technologies
NALA Systems, Inc.
Newsco Inc
One Donation
OpiAID, LLC
PERMITS.com
Phase Dock, Inc.
PhosphoGam
Plakous Therapeutics, Inc.
Plan2Play
Point Motion Inc.
PrimeNeuro
Protect3d
Protopia
QATCH Technologies
Redbud Labs
Reflekt Me, inc.
RelayOne
Renovian, Inc.
Revibe Technologies
Snthesis Inc
Sparta BioMedical Inc.
Squirrel Compliancy Solutions, Inc.
Startomatic
Sunder Networks
Sweetie Pie Organics
Swell Systems, Inc.
Threat Sketch, LLC
Trio Labs
TRPBlue Inc.
Tunnel International Inc
URO-1, Inc.
Venti LLC
VitalFlo Inc.
Xilis, Inc.
Register for Venture Connect
Registration is OPEN and will run through March 11. Early ticket prices are $350 for entrepreneurs and $650 for General attendees. A ticket will include – three days of nonstop content, a keynote lunch, networking receptions, one-on-one meeting access, and more. Regular rates begin on February 15 and prices increase to $500 and $950 respectively, so get your tickets early! Visit the CED website to purchase tickets and for further information.
The conference is presented in partnership with the North Carolina Biotechnology Center and the North Carolina Biosciences Organization.
Media interested in attending the conference should contact Kristina Sandine at ksandine@cednc.org or 919-226-0470.